Fill-me
Fill-me is an injectable hydrogel specially developed for the correction of soft tissue deficiencies. It is a sterile, non-pyrogenic and injectable product with a monophasic composition. The hydrogel is derived from highly purified, cross-linked sodium hyaluronate from non-animal sources, produced by bacterial fermentation. FillMe is an injectable medical device designed for intradermal administration that offers a temporary solution to congenital or acquired soft tissue deficiencies of the face.
Fill-me is available in three different hyaluronic acid concentrations: Fill-me 1,
Fill-me 2 and Fill-me 3.
FILL-ME 1: as it is moderately cohesive, it is therefore recommended for the correction of lips and fine wrinkles.
Composition: Cross-linked sodium hyaluronate, in sterile buffered water, with the addition of glycine and proline amino acids Cross-linked HA concentration: 22 mg/ml.
Rheological properties: Viscoelastic – Homogeneous – Medium cohesive
Place of injection: Superficially or in the dermis, in the mucous membrane of the mouth.
Needle size: 4 sterile 27G x 1/2″- 13 mm (TSK CE 0123)
Period: 4-5 months
Wrapping: 2 x 1 ml syringes pre-filled
FILL-ME 2: as it is strongly cohesive, it is recommended for the correction of the face and chin, as well as the deepest wrinkles of the nose and eyebrows.
Active ingredients: Cross-linked sodium hyaluronate in sterile buffered water; with the addition of glycine and proline amino acids Cross-linked HA concentration: 24 mg/ml.
Rheological properties: Viscoelastic – Homogeneous – Medium cohesive
Place of injection: Deep or subcutaneous.
Needle size:
- 2 sterile 27G x 1/2″ -13mm (TSK CE 0123)
- 2 sterile 25G x 5/8″ -16mm (Terumo CE 0197)
Period: 6-7 months
Wrapping: 2 x 1 ml syringes pre-filled
FILL-ME 3: as it is moderately cohesive, it is recommended for the correction of wrinkles, especially nasolabial wrinkles.
Active ingredients: Cross-linked sodium hyaluronate in sterile buffered water; with the addition of glycine and proline amino acids Cross-linked HA concentration: 26 mg/ml.
Rheological properties: Viscoelastic – Homogeneous – Medium cohesive
Place of injection: Superficially or in the dermis, in the mucous membrane of the mouth.
Needle size: 4 sterile 25G x 5/8″ - 16mm (Terumo CE 0197)
Period: 8-9 months
Wrapping: 2 x 1 ml syringes pre-filled